Role of PCSK9 in hallmarks of cancer: From mechanisms to interventions (Review)

dc.contributor.author	Tang, Lijuan
dc.contributor.author	Yao, Shu
dc.contributor.author	Zhu, Yongheng
dc.contributor.author	He, Zongsheng
dc.contributor.author	Ramos-Molina, Bruno
dc.contributor.author	Xu, Yuanchun
dc.date.accessioned	2026-10-28T08:18:18Z
dc.date.available	2026-10-28T08:18:18Z
dc.date.issued	2026-07-15
dc.identifier.citation	Tang L, Yao S, Zhu Y, He Z, Ramos-Molina B, Xu Y. Role of PCSK9 in hallmarks of cancer: From mechanisms to interventions (Review). Oncol Lett. 15 de julio de 2026;32(3):1-17. doi:10.3892/ol.2026.15767
dc.identifier.issn	1792-1074
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/29065
dc.language.iso	eng
dc.publisher	SPANDIDOS PUBL LTD
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es	*
dc.title	Role of PCSK9 in hallmarks of cancer: From mechanisms to interventions (Review)
dc.type	info:eu-repo/semantics/article
dc.relation.publisherversion	http://www.spandidos-publications.com/10.3892/ol.2026.15767
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.3892/ol.2026.15767
dc.journal.title	Oncology Letters
dc.identifier.essn	1792-1082